Best Stocks Under $20 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $20.00 (20 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Curaleaf OTCMKTS:CURLF$3.54 +0.13 (+3.81%) As of 12:53 PM EasternCuraleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. More about CuraleafMarket Capitalization$2.47 billionConsensus RatingStrong BuyVolume543,393 sharesAverage Volume1.08 million sharesToday's Range$3.33▼$3.6250-Day Range$1.89▼$3.99 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Industria de Diseno Textil OTCMKTS:IDEXY$15.72 +0.10 (+0.64%) As of 12:53 PM EasternIndustria de Diseño Textil, SA engages in the retail and online distribution of clothing, footwear, accessories, and household products. More about Industria de Diseno TextilMarket Capitalization$195.98 billionP/E Ratio27.34Consensus RatingBuyVolume158,932 sharesAverage Volume713,650 sharesToday's Range$15.61▼$15.793. Ur Energy NYSEAMERICAN:URG$1.98 +0.05 (+2.33%) As of 01:13 PM Eastern This is a fair market value price provided by Massive. Learn more.Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur EnergyMarket Capitalization$780.75 millionConsensus RatingBuyConsensus Price Target$2.57 (+30.0% Upside)Volume3.96 million sharesAverage Volume9.39 million sharesToday's Range$1.88▼$1.974. Neste OYJ OTCMKTS:NTOIY$16.89 -0.54 (-3.10%) As of 12:43 PM EasternNeste Oyj provides renewable diesel and sustainable aviation fuel in Finland, and other Nordic countries, Baltic Rim, other European countries, North and South America, and internationally. More about Neste OYJMarket Capitalization$25.95 billionP/E Ratio31.28Consensus RatingBuyVolume17,125 sharesAverage Volume55,334 sharesToday's Range$16.66▼$16.965. Ascentage Pharma Group International NASDAQ:AAPG$18.42 +0.55 (+3.08%) As of 01:09 PM Eastern This is a fair market value price provided by Massive. Learn more.Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. More about Ascentage Pharma Group InternationalMarket Capitalization$1.72 billionConsensus RatingBuyConsensus Price Target$46.67 (+153.3% Upside)Volume1,743 sharesAverage Volume4,520 sharesToday's Range$18.07▼$18.306. Orla Mining NYSEAMERICAN:ORLA$11.46 +0.22 (+1.91%) As of 01:12 PM Eastern This is a fair market value price provided by Massive. Learn more.Orla Mining Ltd. acquires, explores, develops, and exploits mineral properties. The company explores for gold, silver, zinc, lead, and copper deposits. More about Orla MiningMarket Capitalization$3.97 billionP/E Ratio16.89Consensus RatingBuyConsensus Price Target$27.00 (+135.7% Upside)Volume2.69 million sharesAverage Volume2.65 million shares7. Lynas Rare Earths OTCMKTS:LYSDY$13.30 -0.41 (-2.97%) As of 12:51 PM EasternLynas Rare Earths Limited, together with its subsidiaries, engages in the exploration, development, mining, extraction, and processing of rare earth minerals in Australia and Malaysia. More about Lynas Rare EarthsMarket Capitalization$13.39 billionConsensus RatingBuyVolume64,242 sharesAverage Volume356,720 sharesToday's Range$13.00▼$13.6050-Day Range$12.76▼$15.588. Marks and Spencer Group OTCMKTS:MAKSY$9.94 +0.13 (+1.28%) As of 12:52 PM EasternMarks and Spencer Group plc operates various retail stores. It operates through five segments: UK Clothing & Home, UK Food, International, Ocado, and All Other. More about Marks and Spencer GroupMarket Capitalization$10.26 billionConsensus RatingBuyVolume50,861 sharesAverage Volume187,249 sharesToday's Range$9.89▼$9.9850-Day Range$8.36▼$10.009. Ivanhoe Electric NYSEAMERICAN:IE$13.52 +0.16 (+1.17%) As of 01:13 PM Eastern This is a fair market value price provided by Massive. Learn more.Ivanhoe Electric Inc explores and develops metals and mineral. The company provides Typhoon data acquisition system, a geophysical system that offers primary signal. More about Ivanhoe ElectricMarket Capitalization$2.14 billionConsensus RatingBuyConsensus Price Target$17.88 (+32.3% Upside)Volume722,552 sharesAverage Volume2.04 million sharesToday's Range$13.25▼$13.8810. Element Fleet Management OTCMKTS:ELEEF$18.98 +0.23 (+1.23%) As of 09:55 AM EasternElement Fleet Management Corp. operates as a fleet management company primarily in Canada, Mexico, Australia, and New Zealand. More about Element Fleet ManagementMarket Capitalization$7.52 billionP/E Ratio25.65Consensus RatingBuyVolume1,007 sharesAverage Volume29,846 sharesToday's Range$18.98▼$18.9811. Innovative Solutions and Support NASDAQ:ISSC$17.43 +0.52 (+3.07%) As of 01:12 PM Eastern This is a fair market value price provided by Massive. Learn more.Innovative Solutions and Support, Inc, a systems integrator, designs, develops, manufactures, sells, and services flight guidance, autothrottles, and cockpit display systems in the United States and internationally. More about Innovative Solutions and SupportMarket Capitalization$311.39 millionP/E Ratio18.52Consensus RatingBuyConsensus Price Target$16.25 (-6.8% Downside)Volume114,778 sharesAverage Volume585,996 shares12. SURO Capital NASDAQ:SSSS$14.29 +0.06 (+0.43%) As of 01:12 PM Eastern This is a fair market value price provided by Massive. Learn more.SuRo Capital Corp. is a business development company. The firm seeks to invest in growth capital, late stage and venture capital-backed private companies. More about SURO CapitalMarket Capitalization$372.57 millionP/E Ratio2.05Consensus RatingBuyConsensus Price Target$15.00 (+5.0% Upside)Volume121,924 sharesAverage Volume280,388 shares13. iBio NASDAQ:IBIO$1.94 +0.10 (+5.16%) As of 01:12 PM Eastern This is a fair market value price provided by Massive. Learn more.iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBioMarket Capitalization$96.13 millionConsensus RatingBuyConsensus Price Target$4.75 (+145.5% Upside)Volume572,161 sharesAverage Volume1.38 million sharesToday's Range$1.83▼$2.0014. Select Water Solutions NYSE:WTTR$19.21 +0.23 (+1.21%) As of 01:13 PM Eastern This is a fair market value price provided by Massive. Learn more.Select Water Solutions, Inc, together with its subsidiaries, provides water management and chemical solutions to the energy industry in the United States. More about Select Water SolutionsMarket Capitalization$2.65 billionP/E Ratio91.31Consensus RatingBuyConsensus Price Target$22.40 (+16.6% Upside)Volume336,698 sharesAverage Volume1.64 million shares15. Byrna Technologies NASDAQ:BYRN$6.16 +0.14 (+2.31%) As of 01:13 PM Eastern This is a fair market value price provided by Massive. Learn more.Byrna Technologies Inc, a non-lethal defense technology company, provides non-lethal alternative solutions for law enforcement and private security. More about Byrna TechnologiesMarket Capitalization$139.75 millionP/E Ratio17.11Consensus RatingBuyConsensus Price Target$12.13 (+96.9% Upside)Volume114,830 sharesAverage Volume531,256 shares16. Inhibikase Therapeutics NASDAQ:IKT$1.70 +0.04 (+2.10%) As of 01:13 PM Eastern This is a fair market value price provided by Massive. Learn more.Inhibikase Therapeutics, Inc, a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. More about Inhibikase TherapeuticsMarket Capitalization$225.11 millionConsensus RatingBuyConsensus Price Target$5.50 (+222.6% Upside)Volume137,273 sharesAverage Volume1.41 million sharesToday's Range$1.69▼$1.7317. Exodus Movement NYSEAMERICAN:EXOD$6.60 -0.08 (-1.12%) As of 01:13 PM Eastern This is a fair market value price provided by Massive. Learn more.Exodus Movement, Inc develops blockchain asset investors platform to secure, exchange and manage wealth inside one application. More about Exodus MovementMarket Capitalization$198.28 millionConsensus RatingBuyConsensus Price Target$23.50 (+255.8% Upside)Volume37,712 sharesAverage Volume85,868 sharesToday's Range$6.56▼$6.9018. Aclaris Therapeutics NASDAQ:ACRS$4.57 +0.15 (+3.30%) As of 01:12 PM Eastern This is a fair market value price provided by Massive. Learn more.Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris TherapeuticsMarket Capitalization$638.94 millionConsensus RatingBuyConsensus Price Target$11.50 (+151.9% Upside)Volume265,789 sharesAverage Volume1.93 million sharesToday's Range$4.42▼$4.6319. Equinox Gold NYSEAMERICAN:EQX$11.58 +0.36 (+3.16%) As of 01:13 PM Eastern This is a fair market value price provided by Massive. Learn more.Equinox Gold Corp. engages in the exploration, acquisition, development, and operation of mineral properties in the Americas. More about Equinox GoldMarket Capitalization$9.15 billionP/E Ratio14.49Consensus RatingBuyConsensus Price Target$17.00 (+46.9% Upside)Volume6.11 million sharesAverage Volume10.16 million shares20. Tele2 OTCMKTS:TLTZY$9.26 -0.27 (-2.83%) As of 12:43 PM EasternTele2 AB (publ) provides fixed and mobile connectivity, handset related data services, and entertainment services in Sweden, Lithuania, Latvia, and Estonia. More about Tele2Market Capitalization$12.69 billionP/E Ratio11.87Consensus RatingBuyVolume34,558 sharesAverage Volume45,022 sharesToday's Range$9.23▼$9.4221. Crescent Biopharma NASDAQ:CBIO$17.76 -0.22 (-1.22%) As of 01:12 PM Eastern This is a fair market value price provided by Massive. Learn more.Crescent Biopharma, Inc operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. More about Crescent BiopharmaMarket Capitalization$489.47 millionConsensus RatingBuyConsensus Price Target$28.00 (+57.7% Upside)Volume58,165 sharesAverage Volume238,893 sharesToday's Range$17.71▼$18.8022. Perspective Therapeutics NYSEAMERICAN:CATX$3.26 -0.30 (-8.29%) As of 01:13 PM Eastern This is a fair market value price provided by Massive. Learn more.Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective TherapeuticsMarket Capitalization$373.51 millionConsensus RatingBuyConsensus Price Target$12.63 (+286.7% Upside)Volume2.25 million sharesAverage Volume2.57 million sharesToday's Range$3.26▼$3.6323. Inventiva NASDAQ:IVA$4.32 +0.28 (+6.81%) As of 01:12 PM Eastern This is a fair market value price provided by Massive. Learn more.Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. More about InventivaMarket Capitalization$896.27 millionConsensus RatingBuyConsensus Price Target$16.56 (+283.7% Upside)Volume1.09 million sharesAverage Volume433,703 sharesToday's Range$3.98▼$4.4924. Bayer Aktiengesellschaft OTCMKTS:BAYRY$10.29 +0.35 (+3.47%) As of 12:53 PM EasternBayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. More about Bayer AktiengesellschaftMarket Capitalization$40.42 billionConsensus RatingBuyVolume2.94 million sharesAverage Volume1.38 million sharesToday's Range$10.23▼$10.3050-Day Range$9.88▼$12.1225. Larimar Therapeutics NASDAQ:LRMR$3.18 -0.02 (-0.69%) As of 01:13 PM Eastern This is a fair market value price provided by Massive. Learn more.Larimar Therapeutics, Inc, a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. More about Larimar TherapeuticsMarket Capitalization$330.13 millionConsensus RatingBuyConsensus Price Target$15.29 (+381.0% Upside)Volume758,760 sharesAverage Volume3.10 million sharesToday's Range$3.16▼$3.35 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas From Runway to Riches: Victoria's Secret's New Look Coke's $10B India IPO Plan Pops the Top on Hidden Value Dell's AI Toll Bridge Is Paved with Record Margins The Blue Origin Explosion Is a Setback for Amazon, Not a Dealbreaker Ulta's Q1 Report Primes It for a Beauty of a Rebound Palo Alto Networks Accelerates Growth 31% on AI Demand How the Memory Shortage Is Crushing the Gaming Industry As AI Data Breaches Become More Common, This Cybersecurity ETF Is Surging Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
